Raptor Pharmaceutical Corp (NASDAQ:RPTP)

13.77
Delayed Data
As of 3:59pm ET
 -0.72 / -4.97%
Today’s Change
7.85
Today|||52-Week Range
16.28
+30.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.2B

Company Description

Raptor Pharmaceutical Corp. is a biopharmaceutical company, which focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. It has active development programs in cystinosis, a rare genetic disease, as well as other genetic and metabolic disorders. Raptor Pharmaceutical Corp was founded by Christopher M. Starr & Todd C. Zankel on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
7 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional24.68%
Individual stakeholders22.14%
Mutual fund holders20.71%

Top Executives

Julie Anne SmithPresident, Chief Executive Officer & Director
Michael P. SmithCFO, Secretary, Treasurer & CAO
Todd C. ZankelChief Scientific Officer
Krishna R. PoluChief Medical Officer
Paul K. RossChief Compliance Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account